Chemoinformaics analysis of 2,3,5-Trimethylpyrazine
Molecular Weight | 122.171 | nRot | 0 |
Heavy Atom Molecular Weight | 112.091 | nRig | 6 |
Exact Molecular Weight | 122.084 | nRing | 1 |
Solubility: LogS | 0.191 | nHRing | 1 |
Solubility: LogP | 0.964 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 20.5579 |
nHD | 0 | BPOL | 12.3121 |
QED | 0.519 |
Synth | 2.23 |
Natural Product Likeliness | -1.059 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.007 |
HIA | 0.006 |
CACO-2 | -4.632 |
MDCK | 0.0000277 |
BBB | 0.967 |
PPB | 0.491149 |
VDSS | 1.488 |
FU | 0.594979 |
CYP1A2-inh | 0.408 |
CYP1A2-sub | 0.86 |
CYP2c19-inh | 0.022 |
CYP2c19-sub | 0.681 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.238 |
CYP2d6-inh | 0.023 |
CYP2d6-sub | 0.809 |
CYP3a4-inh | 0.009 |
CYP3a4-sub | 0.438 |
CL | 7.265 |
T12 | 0.346 |
hERG | 0.016 |
Ames | 0.022 |
ROA | 0.615 |
SkinSen | 0.624 |
Carcinogencity | 0.788 |
EI | 0.988 |
Respiratory | 0.906 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.902072 |